Tourmaline Bio Inc (NASDAQ:TRML) traded at $13.83 at close of the session on current trade day and made an upward move of 5.65% on its previous day’s price.
Looking at the stock we see that its previous close was $13.09 with the day’s price range being $13.15 – $13.965. In terms of its 52-week price range, TRML has a high of $48.31 and a low of $12.12. The company’s stock has lost about -24.18% over that past 30 days.
Tourmaline Bio Inc has a market cap of $354.60 million and is expected to release its quarterly earnings report in March.
On the other hand, looking at the outlook for the TRML stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is -12.23% off its SMA20 and -28.11% from its 50-day simple moving average. The RSI (14) is pointing at 31.51 while the volatility over the past week is 5.85% and jumps to 5.55% over the past one month. The beta value is 2.34, while the average true range (ATR) is currently pointing at 0.98. The average price target for the stock over the next 12 months is $50, with the estimates having a low of $50 and a high of $50. These price ends are -261.53% and -261.53% off the current price level respectively, although investors could be excited at the prospect of a -261.53% if the TRML share price touches on the median price of $50.
Coming back to Tourmaline Bio Inc (NASDAQ:TRML), we note that the average 3-month trading volume was 249.23K, while that of the preceding 10-day period stands at 0.43 million. Current shares outstanding are 25.64 million.
The insiders hold 39.18% of the company’s shares while institutions hold 68.52%. The data shows that short shares as of 2025-01-31, stood at 2.71 million at a short ratio of 11.75. This represents a 1184.00 short interest in shares outstanding on 2025-01-31. Shares short rose in January from the previous month at 2.08 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -31.80% down in year-to-date price movement.
